Akron Pharma, Inc.: Drug Recall
Recall #D-0025-2025 · 10/15/2024
Class II: Risk
Recall Details
- Recall Number
- D-0025-2025
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- Akron Pharma, Inc.
- Status
- Ongoing
- Date Initiated
- 10/15/2024
- Location
- Fairfield, NJ, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 10845 bottles
Reason for Recall
CGMP Deviations
Product Description
OneLAX Docusate Sodium Liquid (docusate sodium 50 mg/5 mL) Stool Softener Laxative, 16 FL OZ (473 mL) bottle, Akron Pharma, Manufactured for: Akron Pharma, Inc., Fairfield, NJ 07004, NDC 71399-0039-06.
Distribution Pattern
Nationwide in the US
Other Recalls by Akron Pharma, Inc.
- Class III: Low Risk 12/12/2024
- Class III: Low Risk 12/12/2024
- Class III: Low Risk 12/12/2024
- Class III: Low Risk 12/12/2024
- Class III: Low Risk 12/12/2024
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.